BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22369110)

  • 21. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation.
    Mukhopadhyay A; Banerjee S; Stafford LJ; Xia C; Liu M; Aggarwal BB
    Oncogene; 2002 Dec; 21(57):8852-61. PubMed ID: 12483537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-proliferative effects of the novel squamosamide derivative (FLZ) on HepG2 human hepatoma cells by regulating the cell cycle-related proteins are associated with decreased Ca(2+)/ROS levels.
    Qin Y; Pan X; Tang TT; Zhou L; Gong XG
    Chem Biol Interact; 2011 Sep; 193(3):246-53. PubMed ID: 21835169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation.
    Sanmartín-Salinas P; Lobo MDVT; Noguerales-Fraguas F; Londoño MT; Jiménez-Ruiz A; Guijarro LG
    J Gastroenterol; 2018 Aug; 53(8):932-944. PubMed ID: 29353348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
    Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells.
    Masamha CP; Benbrook DM
    Cancer Res; 2009 Aug; 69(16):6565-72. PubMed ID: 19638577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells.
    Hsieh TC; Yang CJ; Lin CY; Lee YS; Wu JM
    Carcinogenesis; 2012 Mar; 33(3):670-7. PubMed ID: 22266466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest.
    Srethapakdi M; Liu F; Tavorath R; Rosen N
    Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The involvement of cyclin D1 degradation through GSK3β-mediated threonine-286 phosphorylation-dependent nuclear export in anti-cancer activity of mulberry root bark extracts.
    Eo HJ; Park GH; Jeong JB
    Phytomedicine; 2016 Feb; 23(2):105-13. PubMed ID: 26926171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FTY720 induces apoptosis of human hepatoma cell lines through PI3-K-mediated Akt dephosphorylation.
    Lee TK; Man K; Ho JW; Sun CK; Ng KT; Wang XH; Wong YC; Ng IO; Xu R; Fan ST
    Carcinogenesis; 2004 Dec; 25(12):2397-405. PubMed ID: 15297371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The retinoblastoma gene product inhibits TGF-beta1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells.
    Fan G; Ma X; Kren BT; Steer CJ
    Oncogene; 1996 May; 12(9):1909-19. PubMed ID: 8649852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy.
    Dragnev KH; Pitha-Rowe I; Ma Y; Petty WJ; Sekula D; Murphy B; Rendi M; Suh N; Desai NB; Sporn MB; Freemantle SJ; Dmitrovsky E
    Clin Cancer Res; 2004 Apr; 10(7):2570-7. PubMed ID: 15073138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus X induces cell proliferation in the hepatocarcinogenesis via up-regulation of cytoplasmic p21 expression.
    Yano M; Ohkoshi S; Aoki YH; Takahashi H; Kurita S; Yamazaki K; Suzuki K; Yamagiwa S; Sanpei A; Fujimaki S; Wakai T; Kudo SE; Matsuda Y; Aoyagi Y
    Liver Int; 2013 Sep; 33(8):1218-29. PubMed ID: 23590292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticancer activity of calyx of Diospyros kaki Thunb. through downregulation of cyclin D1 via inducing proteasomal degradation and transcriptional inhibition in human colorectal cancer cells.
    Park SB; Park GH; Song HM; Son HJ; Um Y; Kim HS; Jeong JB
    BMC Complement Altern Med; 2017 Sep; 17(1):445. PubMed ID: 28870200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
    Wang Z; Wei W; Sun CK; Chua MS; So S
    Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
    Lai S; El-Naggar AK
    Lab Invest; 1999 Mar; 79(3):255-60. PubMed ID: 10092061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression.
    Song S; Krishnan K; Liu K; Bresalier RS
    Clin Cancer Res; 2009 Jan; 15(2):622-31. PubMed ID: 19147768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GL331 induces down-regulation of cyclin D1 expression via enhanced proteolysis and repressed transcription.
    Lin S; Huang HC; Chen LL; Lee CC; Huang TS
    Mol Pharmacol; 2001 Oct; 60(4):768-75. PubMed ID: 11562439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway.
    Jung JK; Arora P; Pagano JS; Jang KL
    Cancer Res; 2007 Jun; 67(12):5771-8. PubMed ID: 17575144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol.
    Alinari L; Prince CJ; Edwards RB; Towns WH; Mani R; Lehman A; Zhang X; Jarjoura D; Pan L; Kinghorn AD; Grever MR; Baiocchi RA; Lucas DM
    Clin Cancer Res; 2012 Sep; 18(17):4600-11. PubMed ID: 22791882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
    Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
    Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.